86
Views
109
CrossRef citations to date
0
Altmetric
Review Article

An Overview of the Interferon System: Signal Transduction and Mechanisms of Action

&
Pages 25-53 | Published online: 11 Jun 2009

References

  • Interferons and Other Regulatory Cytokines, E De Maeyer, J DeMaeyer-Guignard. Wiley Interscience, New York 1988
  • Isaacs A, Lindenmann J. Viral interference I. The interferon. Proc R Soc Lond B Biol Sci 1957; 147: 258–267
  • Pestka S, Langer J, Zoon K, et al. Interferons and their actions. Annu Rev Biochem 1987; 56: 727–777
  • Gresser I. Antitumor effects of interferons: Past, present, and future. Br J Haematol 1991; 79: 1–5
  • Samuel C. Antiviral actions of interferon: Interferon-regulated proteins and their surprisingly selective antiviral activities. Virology 1991; 183: 1–11
  • Borden E C. Interferons. Cancer Medicine, J F Holland, E F Frei, III, R C Bast, D W Kufe, D L Morton, R R Weichselbaum. Lea & Febiger, Philadelphia 1993; 927–936
  • Sen G C, Ransohoff R M. Interferon-induced antiviral actions and their regulation. Adv Virus Res 1993; 42: 57–101
  • Haines D S, Strauss K I, Gillespie D H. Cellular response to double stranded RNA. J Cell Biochem 1991; 46: 9–20
  • Reis L F, Ho L T, Vilcek J. Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts. J Biol Chem 1989; 264: 16351–16354
  • Marcus P, Sekellick M. Defective interfering particles with covalently linked [±] RNA induce interferon. Nature 1977; 266: 815–819
  • Diaz M O, Bohlander S, Allen G. Nomenclature of human interferon genes. J Interferon Res 1993; 13: 234–243
  • Harada H, Willison K, Sakakibara J, et al. Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and represser (IRF-2) genes are developmentally regulated. Cell 1990; 63: 303–312
  • Ringold G, Dieckmann B, Vannice J. Inhibition of protein synthesis stimulates the transcription of human beta-interferon gene in Chinese hamster ovary cells. Proc Natl Acad Sci USA 1984; 81: 3964–3968
  • Dinter H, Hauser H. Superinduction of the human interferon-β promoter. EMBO J 1987; 6: 599–604
  • Steward W E, II, Gosser L B, Lockart R Z, Jr. The effect of priming with interferon on interferon production by two lines of L cells. J Gen Virol 1972; 15: 85–87
  • Tanaka N, Taniguchi T. Cytokine gene regulation: Regulatory cis elements and DNA binding factors involved in the interferon system. Adv Immunol 1992; 52: 263–281
  • Goodboum S, Maniatis T. Overlapping positive and negative regulatory domains of the human β-interferon gene. Proc Natl Acad Sci USA 1988; 85: 1447–1451
  • Fujita T, Shibuya H, Hotta H, et al. Interferon-β gene regulation: Tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer. Cell 1987; 49: 357–367
  • Kuhl D, de la Fuente J, Chaturvedi M, et al. Reversible silencing of enhancers by sequences derived from the human IFN-α promoter. Cell 1987; 50: 1057–1069
  • Fujita T, Kimura Y, Miyamoto M, et al. Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1. Nature 1989; 337: 270–272
  • Harada H, Fujita T, Miyamoto M, et al. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 1989; 58: 729–739
  • Watanabe N, Sakakibara J, Hovanessian A, et al. Activation of IFN-element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis. Nucleic Acid Res 1991; 19: 4421–4428
  • Palombella V J, Maniatis T. Inducible processing of interferon regulatory factor-2. Mol Cell Biol 1992; 12: 3325–3336
  • Sims S H, Cha Y, Romine M F, et al. A novel interferon-inducible domain: Structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol Cell Biol 1993; 13: 690–702
  • Yamada G, Ogawa M, Akagi K, et al. Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice. Proc Natl Acad Sci USA 1991; 88: 532–536
  • Watanabe N, Sakakibara J, Taniguchi T, et al. Identification and characterization of a novel DNA binding factor v-IRF-1, a candidate activator of the IFN-β gene. J Interferon Res 1993; 13(Suppl 1)S177
  • Fujita T, Reis L, Watanabe N, et al. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc Natl Acad Sci USA 1989; 86: 9936–9340
  • Keller A, Maniatis T. Identification and characterization of a novel repressor of β-interferon gene expression. Genes Dev 1991; 5: 868–879
  • Fujita T, Miyamoto M, Kimura Y, et al. Involvement of a cis-element that binds an H2TF-1/NF-kB like factor(s) in the virus-induced interferon-beta gene expression. Nucleic Acids Res 1989; 17: 3335–3347
  • Lenardo M, Fan C, Maniatis T, et al. The involvement of NF-kB in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 1989; 57: 287–294
  • Viswanathan K, Goodbourn S. Double-stranded RNA activates binding of NF-kB to an inducible element in the human β-interferon promoter. EMBO J 1989; 8: 1129–1138
  • Baeuerle P, Baltimore D. The physiology of the NF-kB transcription factor. The Hormonal Control of Gene Expression, P Cohen, J G Foulkes. Elsevier, Amsterdam 1991; 423–446
  • Beg A A, Baldwin A S, Jr. The IkB-proteins: Multifunctional regulators of rel/NF-kB transcription factors. Genes Dev 1993; 7: 2064–2070
  • Blank V, Kourilsky P, Israel A. NF-kB and related proteins: Rel/dorsal homologies meet ankyrin-like repeats. Trends Biochem Sci 1992; 17: 135–140
  • Havell E, Hayes T, Vilcek J. Synthesis of two distinct interferons by human fibroblasts. Virology 1978; 89: 330–334
  • Ryals J, Dierks Ragg P. H, et al. A 46-nucleotide promoter segment from an IFN-α gene renders unrelated promoter inducible by virus. Cell 1985; 41: 497–507
  • Mac Donald N, Kuhl D, Maguire D, et al. Different pathways mediate virus inducibility of the human IFN-αl and IFN-β genes. Cell 1990; 60: 767–779
  • Au W-C, Raj N BK, Pine R, et al. Distinct activation of murine interferon-promoter region by IRF-l/ISGF-2 and virus infection. Nucleic Acids Res 1992; 20: 1531–1538
  • Raj N, Au W-C, Pitha P. Identification of a novel virus-responsive sequence in the promoter of murine interferon-α genes. J Biol Chem 1991; 266: 11360–11365
  • Heron I, Hokland M, Berg K. 13 native interferons-alpha species assessed for immunoregulatory properties. J Interferon Res 1983; 3: 231–239
  • Young H A, Hardy K J. Interferon-gamma: Producer cells, activation stimuli, and molecular genetic regulation. Pharm Ther 1990; 45: 137–151
  • Pang Y, Norihisa Y, Benjamin D, et al. Interferon-gamma gene expression in human B-cell lines: Induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation. Blood 1992; 80: 724–32
  • Hardy K J, Young H A. IFN-gamma: Gene structure and regulation. Interferons: Principles and Medical Application, S Baron, D H Coppenhaver, F Dianzani. University of Texas Medical Branch Press, Galveston 1992; 47–64
  • Farrar W L, Birchenall S M, Young H B. Interleukin-2 induction of interferon-gamma mRNA synthesis. J Immunol 1986; 137: 3836–3840
  • Chan S H, Kobayashi M, Santoli D, et al. Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/ IL-12): Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol 1992; 148: 92–98
  • Recht M, Borden E C, Knight E, Jr. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol 1991; 147: 2617–2623
  • Ciccarone V C, Chrivia J, Hardy K J, et al. Identification of enhancer-like elements in human IFN-gamma genomic DNA. J Immunol 1990; 144: 725–730
  • Sica A, Tan T-H, Rice N, et al. The c-rel protooncogene product c-rel but not NF-kB binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. Proc Natl Acad Sci USA 1992; 89: 1740–1744
  • Brown D A, Kondo K L, Wong S W, et al. Characterization of nuclear protein binding to the interferon-gamma promoter in quiescent and activated human T cells. Eur J Immunol 1992; 22: 2419–2428
  • Brown D A, Nelson F B, Reinherz E L, et al. The human interferongamma gene contains an inducible promoter than can be transactivated by tax I and II. Eur J Immunol 1991; 21: 1879–1885
  • Cross J, Roberts R. Constitutive and trophoblast-specific expression of a class of bovine interferon genes. Proc Natl Acad Sci USA 1991; 88: 3817–3821
  • Roberts R M, Cross J C, Leaman D W. Unique features of the trophoblast interferons. Pharm Ther 1991; 51: 329–45
  • Aguet M. Molecular cloning of interferon receptors: A short review. Br J Haematol 1991; 79: 6–8
  • Mariano T M, Donnelly R J, Soh J, . Structure and function of the type I interferon receptor. Interferon: Principles and Medical Applications, S Baron, D H Coppenhaver, F Dianzani, et al. University of Texas Medical Branch, Galveston 1992; 129–138
  • Stuber D, Fountoulakis M, Garrotta G. IFN-receptor: Protein structure and function. Interferon: Principles and Medical Application, S Baron, D H Coppenhaver, F Dianzani. University of Texas Medical Branch, Galveston 1992; 139–150
  • Uze G, Lutfalla G, Gresser I. Genetic transfer of a functional human interferon-α receptor into mouse cells: Cloning and expression of its cDNA. Cell 1990; 60: 225–234
  • Lutfalla G, Gardinar L, Proudhon D, et al. The structure of the human interferon-α/β receptor gene. J Biol Chem 1992; 267: 2802–2809
  • Colamonici O R, Domanski P. Identification of a novel subunit of the type I interferon receptor localized to human chromosome 21. J Biol Chem 1993; 268: 10895–10899
  • Platanias L C, Colamonici O R. Interferon alpha induces rapid tyrosine phosphorylation of the alpha subunit of its receptor. J Biol Chem 1992; 267: 24053–24057
  • Colamonici O R, Uyttendaele H, Domanski P, et al. p135tyk2, an interferon-α-activated tyrosine kinase, is physically associated with an interferon-α receptor. J Biol Chem 1994; 269: 3518–3522
  • Delcayre S, Salas F, Mathur S, et al. Epstein Barr virus/complement C3d receptor is an interferon-α receptor. EMBO J 1991; 10: 919–926
  • Aguet M, Dembic Z, Merlin G. Molecular cloning and expression of the human interferon-gamma receptor. Cell 1988; 55: 273–280
  • Gray P, Leong S, Fennie E, et al. Cloning and expression of the cDNA for the murine interferon-gamma receptor. Proc Natl Acad Sci USA 1989; 86: 8479–8501
  • Hemmi S, Peghini P, Merlin G, et al. Cloning of murine interferongamma receptor cDNA: Expression in human cells mediates high-affinity binding but is not sufficient to confer sensitivity to murine interferon-gamma. Proc Natl Acad Sci USA 1989; 86: 9901–9905
  • Munro S, Maniatis T. Expression cloning of the murine interferongamma receptor cDNA. Proc Natl Acad Sci USA 1989; 86: 9248–9252
  • Jung V, Rashidbaigi A, Jones C, et al. Human chromosome 6 and 21 are required for sensitivity to human interferon. Proc Natl Acad Sci USA 1987; 84: 4151–4155
  • Hibino Y, Kumar C, Mariano T, et al. Chimeric interferon-gamma receptors demonstrate that an accessory factor required for activity interacts with the extracellular domain. J Biol Chem 1992; 267: 3741–3749
  • Hemmi S, Merlin G, Aguet M. Functional characterization of a hybrid human-mouse interferon gamma receptor: Evidence for species-specific interaction of the extracellular receptor domain with a putative signal transducer. Proc Natl Acad Sci USA 1992; 89: 2737–2741
  • Hershey G, McCourt D, Schreiber R. Ligand-induced phosphorylation of the human interferon-gamma receptor. J Biol Chem 1990; 265: 17865–17868
  • Greenlund A C, Farrar M A, Viviano B L, et al. Ligand induced IFN-γ receptor tyrosine phosphorylation couples the receptor to its signal transduction sytem (p91). EMBO J 1994; 13: 1591–1600
  • Huang S, Hendriks W, Althage A, et al. Immune response in mice that lack the interferon-gamma receptor. Science 1993; 259: 1742–1745
  • Branca A, Faltyneck C, D'Alessandro S, et al. Interaction of interferon with cellular receptors: Internalization and degradation of cell-bound interferon. J Biol Chem 1982; 257: 13291–13296
  • Pellegrini S, Schindler C. Early events in signalling by interferons. Trends Biochem Sci 1993; 18: 338–342
  • Friedman R, Manly S, McMahon M, et al. Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 1984; 38: 745–755
  • Hannigan G, Williams B. Transcriptional regulation of interferon-responsive genes is closely linked to interferon receptor occupancy. EMBO J 1986; 5: 1607–1613
  • Tiwari R K, Kusari J, Kumar R, et al. Gene induction by interferons and double-stranded RNA: Selective inhibition by 2-aminopurine. Mol Cell Biol 1988; 8: 4289–4294
  • Bandyopadhyay S K, Kalvakolanu D VR, Sen G C. Gene induction by interferons: Functional complementation of trans-acting factors induced by α-interferon and gamma-interferon. Mol Cell Biol 1990; 10: 5055–5063
  • Kessler D S, Levy D E. Protein kinase activity required for an early step in interferon-signaling. J Biol Chem 1991; 266: 23417–23476
  • Pfeffer L M, Eisenkraft B L, Reich N C, et al. Transmembrane signaling by interferon alpha involves diacylglycerol production and activation of the epsilon isofonn of protein kinase C in Daudi cells. Proc Natl Acad Sci USA 1991; 88: 7988–7992
  • Bandyopadhyay S K, Sen G C. Role of protein phosphorylation in activation of interferon-α stimulated gene factors. J Biol Chem 1992; 267: 6389–6395
  • Wang C, Constantinescu S N, MacEwan D J, et al. Interferon-α induces protein kinase C-ϵ (PKC-ϵ) gene expression and a 4.7-kb PKC-ϵ-related transcript. Proc Natl Acad Sci USA 1993; 90: 6944–6948
  • Stark G R, Kerr I M. Interferon-dependent signaling pathways: DNA elements, transcription factors, mutations, and effects of viral proteins. J Interferon Res 1992; 12: 147–151
  • Hannigan G, Williams B. Signal transduction by interferon-α through arachidonic acid metabolism. Science 1991; 251: 204–207
  • Kalvakolanu D V, Mannino S B, Thornton A, et al. Transcriptional induction of genes by IFN-b in mouse cells is regulated by a transcription factor similar to human ISGF-3. Antiviral Res 1994; 25: 91–103
  • Gutch M J, Daly C, Reich N C. Tyrosine phosphorylation is required for activation of an interferon-α stimulated transcription factor. Proc Naü Acad Sci USA 1992; 89: 11411–11415
  • Schindler C, Shuai K, Prezioso V R, et al. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 1992; 257: 809–812
  • Fu X-Y. A transcriptional factor with SH2 and SH3 domains is directly activated by an interferon α-induced cytoplasmic protein tyrosine kinase(s). Cell 1992; 70: 323–335
  • Pawson T, Gish G D. SH2 and SH3 domains: From structure to function. Cell 1992; 71: 359–362
  • David M, Larner A C. Activation of transcription factors by interferon-alpha in a cell-free system. Science 1992; 257: 813–815
  • Velazquez L, Fellous M, Stark G R, et al. A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 1992; 70: 313–322
  • Muller M, Briscoe J, Laxton C, et al. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and gamma signal transduction. Nature 1993; 366: 129–135
  • Waiting D, Guschin D, Muller M, et al. Complementation by the protein tyrosine kinase JAK-2 of a mutant cell line defective in the interferon-gamma signal transduction pathway. Nature 1993; 366: 166–170
  • Silvennoinen O, Ihle J N, Schlessinger J, et al. Interferon-induced nuclear signaling by Jak protein tyrosine kinases. Nature 1993; 366: 583–585
  • Shuai K, Ziemiecki A, Wilks A F, et al. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 1993; 366: 580–583
  • David M, Grimely P M, Finbloom D S, et al. A nuclear tyrosine phosphatase downregulates interferon-induced gene expression. Mol Cell Biol 1993; 13: 5715–5721
  • Friedman R, Stark G. Alpha-interferon-induced transcription of HLA and metallothionein genes containing homologous upstream sequences. Nature 1985; 314: 637–639
  • Reid L, Brasnett A, Gilbert C, et al. A single DNA response element can confer inducibility by both α-and γ-interferons. Proc Natl Acad Sci USA 1989; 86: 840–844
  • Reich N, Evans B, Levy D, et al. Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci USA 1987; 84: 6394–6398
  • Levy D, Kessler D, Pine R, et al. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev 1988; 2: 383–393
  • Porter A, Chernajovsky Y, Dale T, et al. Interferon response element of the human gene 6–16. EMBO J 1988; 7: 85–92
  • Dale T, Rosen J, Guille M, et al. Overlapping sites for constitutive and induced DNA-binding factors involved in interferon-α stimulated transcription. EMBO J 1989a; 8: 831–839
  • Wathelet M G, Clauss I M, Content J, et al. Regulation of two interferon-inducible human genes by interferon, ploy(rI). poly(rC) and viruses. Eur J Biochem 1988; 174: 323–329
  • Daly C, Reich N C. Double-stranded RNA activates novel factors that bind to the interferon-stimulated response element. Mol Cell Biol 1993; 13: 3756–3764
  • Pine R, Canova A, Schindler C. Tyrosine phosphorylated p91 binds to single element in the ISGF2/IRF-1 promoter to mediate induction by IFNα and IFNγ, and is likely to autoregulate the p91 gene. EMBOJ 1994; 13: 158–167
  • Kanno Y, Kozak C A, Schindler C, et al. The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 subunit (or similar) molecule binds. Mol Cell Biol 1993; 13: 3951–3963
  • Decker T, Lew D, Mirkovitch J, et al. Cytoplasmic activation of GAP, an IFN-γ-regulated DNA-binding factor. EMBO J 1991; 10: 927–932
  • Lew D J, Decker T, Strehlow I, et al. Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol Cell Biol 1991; 11: 182–191
  • Khan K D, Shuai K, Lindwall G, et al. Induction of the Ly-6E/A gene by interferon alpha/beta and gamma requires a DNA element to which a tyrosine-phosphorylated 91-kDa protein binds. Proc Natl Acad Sci USA 1993; 90: 6806–6810
  • Khan K, Lindwall G, Maher S E, et al. Characterization of promoter elements of an interferon-inducible Ly-6E/A differentiation antigen, which is expressed on activated T cells and hematopoietic stem cells. Mol Cell Biol 1990; 10: 5150–5159
  • Boss J, Stominger J. Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. Proc Natl Acad Sci USA 1986; 83: 9139–9143
  • Basta P, Sherman P, Ting J P-Y. Detailed delineation of an inter-feron-γ-responsive element important in human HLA-DR gene expression in a glioblastoma multiforme line. Proc Natl Acad Sci USA 1988; 85: 8618–8622
  • Thanos D, Mavrothalassitis G, Papamatheakis J. Multiple regulatory regions on the 5′ side of the mouse Eα gene. Proc Natl Acad Sci USA 1988; 85: 3075–3079
  • Dedrick R, Jones P. Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factors. Mol Cell Biol 1990; 10: 593–604
  • Tsang S, Nakanishi M, Peterlin B. Mutational analysis of the DRA promoter: cis-acting sequences and trans-acting factors. Mol Cell Biol 1990; 10: 711–719
  • Brown A, Barr C, Ting J-Y. Sequences homologous to class II MHC W, X, and Y elements mediate constitutive and IFN-gamma-induced expression of human class II associated invariant chain. J Immunol 1991; 146: 3183–3189
  • Pearse R N, Reinman R, Ravetch J V. Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: Transcriptional induction by γ-interferon is mediated through common DNA response elements. Proc Natl Acad Sci USA 1991; 88: 11305–11309
  • Pearse R N, Reinman R, Shuai K, et al. Interferon gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3. Proc Natl Acad Sci USA 1993; 90: 4314–4318
  • McKendry R, John J, Flavell D, et al. High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc Natl Acad Sci USA 1991; 88: 11455–11459
  • Yang Z, Sugawara M, Ponath P, et al. Interferon-yresponse region in the promoter of the human DPA gene. Proc Natl Acad Sci USA 1990; 87: 9226–9230
  • Bonni A, Frank D A, Schindler C, et al. Characterization of a pathway for ciliary neurotrophic factor signaling to the nucleus. Science 1993; 262: 1575–1579
  • Fu X-Y, Zhang J-J. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of c-fos gene promoter. Cell 1993; 74: 1135–1145
  • Larner A C, David M, Feldman G M, et al. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 1993; 261: 1730–1732
  • Sodowski H B, Shuai K, Darnell J RJE, et al. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 1993; 261: 1739–1744
  • Silvennoinen O, Schindler C, Schlessinger J, et al. ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. Science 1993; 261: 1736–1739
  • Wegenka U M, Buschmann J, Lutticken C, et al. Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol 1993; 13: 276–288
  • Schmitt-Ney M, Happ B, Ball R K, et al. Developmental and environmental regulation of a mammary gland specific transcription factor essential for transcription of the gene encoding betacasein. Proc Natl Acad Sci USA 1992; 89: 3130–3134
  • Yu-Lee L-Y, Hrachovy J, Stevens A, et al. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol Cell Biol 1991; 10: 3087–3094
  • Schwarz L A, Stevens A M, Hrachovy J A, et al. Interferon regulatory factor-1 is inducible by prolactin, interleukin-2, and concanavalin A in T cells. Mol Cell Endocrinol 1992; 86: 103–110
  • Cohen B, Peretz D, Vaiman D, et al. Enhancer-like interferon responsive sequences of the human murine (2′-5′) oligoadenylate synthetase gene promoters. EMBO J 1998; 7: 1411–1419
  • Kessler D, Levy D, Darnell J E, Jr. Two interferon-induced nuclear factors bind a single promoter element in interferon-stimulated genes. Proc Natl Acad Sci USA 1988; 85: 8521–8525
  • Rutherford M N, Hannigan G E, Williams B RG. Interferon-induced binding of nuclear factors to promoter elements of the 2–5A synthetase gene. EMBO J 1988; 7: 751–759
  • Imam A, Ackrill A, Dale T, et al. Transcription factors induced by interferons-α and-γ. Nucleic Acids Res 1990; 18: 6573–6580
  • Pine R, Decker T, Kessler D S, et al. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both β interferon-and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol Cell Biol 1990; 10: 2448–2457
  • Reis L F, Harada H, Wolchok J D, et al. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes. EMBOJ 1992; 11: 185–193
  • Matsuyama T, Kimur T, Kitagawa M, et al. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN-gene induction and aberrant lymphocyte development. Cell 1993; 75: 83–97
  • Ruffner H, Reis L FL, Naf D, et al. Induction of type I interferon genes and interferon-inducible genes in embryonal stem cells devoid of interferon regulatory factor 1. Proc Nati Acad Sci USA 1993; 90: 11503–11507
  • Levy D E, Kessler D S, Pine R, et al. Cytoplasmic activation of ISGF3, the positive regulator of interferon-α-stimulated transcription, reconstituted in vitro. Genes Dev 1989; 3: 1362–1371
  • Dale T, Imam A, Kerr I, et al. Rapid activation by interferon-α of a latent DNA-binding protein present in the cytoplasm of untreated cells. Proc Natl Acad Sci USA 1989; 86: 1203–1207
  • Fu X-Y, Kessler D S, Veals S A, et al. ISGF3, the transcriptional activator induced by interferon-α, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci USA 1990; 87: 8555–8559
  • Kessler D S, Veals S A, Fu X-Y, et al. Interferon-α regulated nuclear translocation and DNA-binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev 1990; 4: 1753–1765
  • Veals S A, Schindler C, Leonard D, et al. Subunit of an alpha-interferon-responsive transcription factor is related to interferon regulatory factor and Myb families of DNA-binding proteins. Mol Cell Biol 1992; 12: 3315–3324
  • Fu X-Y, Schindler C, Improta T, et al. The proteins of ISGF-3, the interferon α-induced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci USA 1992; 90: 7840–7843
  • Schindler C, Fu X-Y, Improta T, et al. Proteins of a transcription factor ISGF-3: One gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by inteferon. Proc Natl Acad Sci USA 1992b; 90: 7836–7839
  • Driggers P, Ennist D, Gleason S, et al. An interferon-γ regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc Natl Acad Sci USA 1991; 87: 3743–3747
  • Veals S A, Maria T S, Levy D E. Two domains of ISGF3 that mediate protein-DNA and protein-protein interacting during transcriptional factor assembly contribute to DNA-binding specificity. Mol Cell Biol 1993; 13: 196–206
  • Nelson N, Marks M S, Driggers P H, et al. Interferon consensus sequence-binding protein, a member of interferon regulatory factor family, suppresses interferon-induced gene transcription. Mol Cell Biol 1993; 13: 588–599
  • Muller M, Laxton C, Briscoe J, et al. Complementation of a mutant cell line: Central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and-γ signal transduction pathways. EMBO J 1993; 11: 4221–4228
  • Shuai K, Schindler C, Prezioso Vr, et al. Activation of transcription of IFN-γ: Tyrosine phosphorylation of a 91-kDa DNA binding protein. Science 1992; 258: 1808–1812
  • Shuai K, Stark G R, Kerr I M, et al. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science 1993; 261: 1744–1746
  • Wathelet M G, Clauss I M, Paillard F, et al. 2-Aminopurine selectively blocks the transcriptional activation of cellular genes by virus, double-stranded RNA and interferons in human cells. Eur J Biochem 1989; 184: 503–509
  • Wathelet M G, Berr P M, Huez G A. Regulation of gene expression by cytokines and virus in human cells lacking the type I interferon locus. Eur J Biochem 1992; 206: 901–910
  • Bourgeade M F, Laurent-Winter C, Besancon F, et al. Differential kinetics of polypeptide expression and different biological activities in the human fibroblasts response to dsRNA or interferon treatment. J Interferon Res 1993; 13: 175–186
  • Yan C, Tamm I. Protein factors that bind to the murine 2′,5′-oligoadenylate synthetase ME-12 gene 5′ upstream regulatory region. J Biol Chem 1990; 265: 20188–20194
  • Yan C, Tamm I. Molecular cloning and characterization of interferon α/β response element binding factors of the murine 2′-5′ oligoadenylate synthetase ME-12 gene. Proc Natl Acad Sci USA 1991; 88: 144–148
  • Yan C, Tamm I. Molecular cloning and characterization of additional factors that bind to the interferon-α/β response element B of the murine 2′-5′ oligoadenylate synthetase ME-12 gene. Proc Natl Acad Sci USA 1992; 89: 8859–8863
  • Kumar A, Rutherford M, Haque S, et al. Proto-oncogene ETS-1 specifically binds the ISRE of 2–5A synthetase. J Interferon Res 1991; 11: 8152
  • Haque S, Kumar A, Fischer T, et al. Trans-repression of the IFN-response by transient expression of IBF-1, and ISRE-binding protein. J Interferon Res 1991; 11: S97
  • Tiwari R K, Kusari J, Sen G C. Functional equivalents of interferon-mediated signals needed for induction of an mRNA can be generated by double-stranded RNA and growth factors. EMBO J 1987; 6: 3373–3378
  • Mundschau L, Faller D. BALB/C-3T3 fibroblasts resistant to growth inhibition by beta interferon exhibit aberrant platelet-derived growth factor, epidermal growth factor, and fibroblast growth factor signal transduction. Mol Cell Biol 1991; 11: 3148–3154
  • Garcia Blanco M, Lengyel P, Morrison E, et al. Regulation of 2′-5′ oligoadenylate synthetase gene expression by interferons and platelet-derived growth factor. Mol Cell Biol 1989; 9: 1060–1068
  • Ruff Jamison S, Chen K, Cohen S. Induction by EGF and interferon-y of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science 1993; 261: 1733–1736
  • Lutticken C, Wegenka U M, Yuan J, et al. Association of transcription factor APRF and protein kinase JAK1 with the interleukin-6 signal transducer gp130. Science 1994; 263: 89–92
  • Stahl N, Boulton T G, Farruggella T, et al. Association and activation of JAK-tyk kinases by CNTF-LIF-OSM-IL-6 receptor components. Science 1994; 263: 92–95
  • Ho A SY, Liu Y, Khan T A, et al. A receptor for interleukin-10 is related to interferon receptors. Proc Natl Acad Sci US A 1993; 90: 11267–11271
  • Argetsinger L S, Campbell G S, Yang X, et al. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 1993; 74: 237–244
  • Witthuhn B A, Queue F W, Silvennoinen O, et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993; 74: 227–236
  • Meyer D J, Campbell G S, Cochran B H, et al. Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor. J Biol Chem 1994; 269: 4701–4704
  • Fox H S, Bond B L, Parslow T G. Estrogen regulates the IFN-y promoter. J Immunol 1991; 146: 4362–4367
  • Rui H, Kirken R A, Farrar W L. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J Biol Chem 1994; 269: 5364–5368
  • Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol 1993; 13: 4531–4538
  • Ackrill A, Reid L, Gilbert C, et al. Differential response of the human 6–16 and 9–27 genes to α and γ interferons. Nucleic Acid Res 1991; 19: 591–598
  • Caplan H, Gupta S. Differential regulation of a cellular gene by human interferon-γ and interferon-α. J Biol Chem 1988; 263: 332–339
  • Staeheli P. Interferon-induced proteins and the antiviral state. Adv Virus Res 1990; 38: 147–199
  • Hovanessian A G. The double-stranded RNA-activated protein kinase induced by interferon: dsRNA-PK. J Interferon Res 1989; 9: 641–647
  • Hovanessian A. Interferon-induced and double-stranded RNA-activated enzymes: A specific protein kinase and 2′-5′ oligoadenyl-ate synthetases. J Interferon Res 1991; 11: 199–205
  • Clemens M J, Hershey J W, Hovanessian A C, et al. PKR: Proposed nomenclature for the RNA dependent protein kinase induced by interferon. J Interferon Res 1993; 13: 241
  • Hovanessian A, Galabru J. The double-stranded RNA-dependent protein kinase is also activated by heparin. Eur J Biochem 1987; 167: 467–473
  • Chen J-J, Throop M S, Gehrke L, et al. Cloning of the cDNA of the heme-regulated eukaryotic initiation factor 2α (eIF-2α) kinase of rabbit reticulocytes: Homology to yeast GCN2 protein kinase and human double-stranded-RNA-dependent eIF-2α kinase. Proc Natl Acad Sci USA 1991; 88: 7729–7733
  • Hershey J W. Translational control in mammalian cells. Annu Rev Biochem 1991; 60: 717–55
  • Black T, Safer B, Hovanessian A, et al. The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: Implications fortranslational regulation. J Virol 1989; 63: 2244–2251
  • Meurs E, Chong K, Galabru J, et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990; 62: 379–390
  • Katze M G, Wambach M, Wong M-L, et al. Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA activated, 68,000-Mr protein kinase in a cell-free system. Mol Cell Biol 1991; 11: 5497–5505
  • Feng G S, Chong K, Kumar A, et al. Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. Proc Natl Acad Sci USA 1992; 89: 5447–5451
  • Patel R C, Sen G C. Identification of the double stranded RNA-binding domain of the human interferon-inducible protein kinase. J Biol Chem 1992; 267: 7671–7676
  • Meurs E F, Watanabe Y, Kadereit S, et al. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J Virol 1992; 66: 5804–5814
  • Koromilas A E, Roy S, Barber G N, et al. Malignant transformation by a mutant of the IFN-inducible dsRNA dependent protein kinase. Science 1992; 257: 1685–1689
  • Meurs E F, Galabru J, Barber G N, et al. Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1993; 90: 232–236
  • Chong K L, Feng L, Schappert K, et al. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J 1992; 11: 1553–1562
  • Kalvakolanu D VR, Bandyopadhyay S K, Tiwari R K, et al. Enhancement of expression of exogenous genes by 2-aminopurine: Regulation at the post transcriptional level. J Biol Chem 1991; 266: 873–879
  • Petryshyn R, Chen J J, London I M. Detection of activated double-stranded RNA-dependent protein kinase in 3T3-F442A cells. Proc Natl Acad Sci USA 1988; 85: 1427–1431
  • Parrel P, Balkow K, Hunt T, et al. Phosphorylation of initiation factor eIF-2 and the control of reticulocyte protein synthesis. Cell 1977; 11: 187–200
  • Choi S-Y, Scherer B J, Schnier J, et al. Stimulation of protein synthesis in COS cells transfected with variants of the α-subunit of initiation factor eIF-2. J Biol Chem 1992; 267: 286–293
  • Zinn K, Keller A, Whittemore L A, et al. 2-Aminopurine selectively inhibits the induction of β-interferon, c-fos, and c-myc gene expression. Science 1988; 240: 210–213
  • Kumar A, Haque J, Lacoste J, et al. Double stranded RNA-dependent protein kinase activates transcription factor NF-kB by phosphorylating IkB. Proc Natl Acad Sci USA 1994; 91: 6288–6292
  • Williams B, Silverman R. The 2–5A System. Clinical and Molecular Aspects of the Interferon Regulated Pathway. Alan R. Liss, New York 1985
  • Saunders M, Gewert D, Tugwell M, et al. Human 2–5A synthetase: Characterization of a novel cDNA and corresponding gene structure. EMBO J 1985; 4: 1761–1768
  • Chebath J, Benech P, Hovanessian A, et al. Four different forms of interferon-induced 2′-5′oligo(A) synthetase identified by im-munoblotting in human cells. J Biol Chem 1987; 262: 3852–3857
  • Ghosh S, Kusari J, Bandyopadhyay S, et al. Cloning, sequencing, and expression of two murine 2′-5′-oligoadenylale synthetases. J Biol Chem 1991; 266: 15293–15299
  • Merlin G, Chebath J, Benech P, et al. Molecular cloning and sequence of partial cDNA for interferon-induced (2′-5′) oligo(A) synthetase mRNA from human cells. Proc Natl Acad Sci USA 1983; 80: 4904–4908
  • St Laurent G, Yoshie O, Floyd-Smith G, et al. Interferon action: Two (2′-5′)(A)n synthetases specified by distinct mRNAs in Ehr-lich ascites tumor cells treated with interferon. Cell 1983; 33: 95–102
  • Marie I, Svab J, Robst N, et al. Differential expression and distinct structure of 69-and 100-kDa forms of 2–5A synthetase inhuman cells treated with interferon. J Biol Chem 1990; 265: 18601–18607
  • Marie I, Hovanessian A G. The 69-kDa 2–5A synthetase is composed of two homologous and adjacent functional domains. J Biol Chem 1992; 267: 9933–9939
  • Hovanessian A, Svab J, Marie I, et al. Characterization of 69-and 100-kDa forms of 2–5A synthetase from interferon-treated human cells. J Biol Chem 1988; 263: 4959–4969
  • Marie I, Svab J, Hovanessian A. The binding of the 69-and 100-kD forms of 2′,5′-oligoadenylate synthetase to different polynucleotides. J Interferon Res 1990; 10: 571–578
  • Silverman R H, Krause D, Jacobsen H, . 2–5A dependent RNase levels vary with interferon treatment, growth rate and cell differentiation. The Biology of Interferon System, E DeMaeyer, H Schellekens, et al. Elesevier, Amsterdam 1983; 189–200
  • Krause D, Silverman R H, Jacobsen H, et al. Regulation of ppp(A2′p)n-dependent RNase levels during interferon treatment and cell differentiation. Eur J Biochem 1985; 146: 611–618
  • Hassel B A, Zhou A, Sotomayor C, et al. A dominant negative mutant of 2–5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 1993; 12: 3297–3304
  • Chebeth J, Benech P, Revel M, et al. Constitutive expression of (2′-5/) oligo A synthetase confers resistance to picornavirus infection. Nature 1987; 330: 587–588
  • Rysiecki G, Gewart D, Williams B. Constitutive expression of a 2′-5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J Interferon Res 1990; 9: 649–657
  • Schroder H C, Ugarkovic D, Merz H, et al. Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2′,5′-oligoadenylate synthetase hybrid gene. FASEB 1990; J4: 3124–3130
  • Sperling J, Chebath J, Arad-Dann H, et al. Possible involvement of (2′-5′)oligoadenylate synthetase activity in pre-mRNA splicing. Proc Natl Acad Sci USA 1991; 88: 10377–10381
  • Kumar R, Mendelsohn J. Role of 2′-5′-oligoadenylate synthetase in γ-interferon-mediated growth inhibition of A431 cells. Cancer Res 1989; 49: 5180–5184
  • Constantoulakis P, Campbell M, Felber B K, et al. Inhibition of Rev-mediated HIV-1 expression by an RNA binding protein encoded by the interferon-inducible 9–27 gene. Science 1993; 259: 1314–1318
  • Staeheli P, Haller O, Boll W, et al. mx protein: Constitutive expression in 3T3 cells transformed with cloned mx cDNA confers selective resistance to influenza virus. Cell 1986; 44: 147–158
  • Arnheiter H, Haller O. Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon-induced mx proteins. EMBO J 1988; 7: 315–1320
  • Arnheiter H, Skuntz S, Noteborn M, et al. Transgenic mice with intracellular immunity to influenza virus. Cell 1990; 62: 51–61
  • Arnheiter H, Meier E. mx proteins: Antiviral by chance or by necessity. New Biol 1990; 2: 851–357
  • Krug R, Shaw M, Broni B, et al. Inhibition of influenza virus messenger RNA synthesis in cells expressing the interferon-induced mx gene product. J Virol 1985; 56: 201–206
  • Huang T, Pavlovic J, Staeheli P, et al. Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mxl protein. J Virol 1992; 66: 4154–4160
  • Pavlovic J, Zurcher T, Haller O, et al. Resistance to influenza and vesicular stomatitis virus conferred by expression of human MxA protein. J Virol 1990; 64: 3370–3375
  • Staeheli P, Pavlovic J. Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J Virol 1991; 65: 4498–4501
  • Zurcher T, Pavlovic J, Staeheli P. Mechanism of human mx A protein action: Variants with changed antiviral properties. EMBO J 1992; 11: 1657–1661
  • Pavlovic J, Haller O, Staeheli P. Human and mouse mx proteins inhibit different steps of the influenza virus multiplication cycle. J Virol 1992; 66: 2564–2569
  • Pitossi F, Blank A, Schroder A, et al. A functional GTP-binding motif is necessary for antiviral activity of mx proteins. J Virol 1993; 67: 6726–6732
  • Rothman J, Raymond C, Gilbert T, et al. A putative GXP binding protein homologous to interferon-inducible mx proteins performs an essential function in yeast protein sorting. Cell 1990; 61: 1063–1074
  • Obar R, Collins C, Hammarback J, et al. Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTP-binding proteins. Nature 1990; 347: 256–261
  • Pfefferkorn E R. Interferon-gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci USA 1984; 81: 908–912
  • Carlin J M, Borden E C, Sondel P M, et al. Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes. J Leuk Biol 1989; 45: 29–34
  • Takikawa O, Kuroiwa T, Yamazaki F, et al. Mechanisms of interferon-gamma action: Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by IFN gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem 1988; 263: 2041–2048
  • Werner E R, Werner-Felmayer G, Fuchs D, et al. Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferongamma. Biochem J 1989; 262: 861–866
  • Ozaki Y, Edelstein M P, Duch D S. Induction of indoleamine 2,3-dioxygenase: A mechanism of the antitumor activity of IFN-gamma. Proc Natl Acad Sci USA 1988; 85: 1242–1246
  • Carlin J M, Borden E C, Byrne G I. Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferonbetaser. J Interferon Res 1989; 9: 167–173
  • Pfefferkorn E R, Eckel M, Rebhun S. Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan. Mol Biochem Parasitol 1986; 20: 215–224
  • Byrne G I, Lehmann L K, Landry G J. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psillaci replication in T24 cells. Infect Immun 1986; 53: 344–351
  • de la Maza L M, Peterson E M. Dependence on the in vitro antiproliferative activity of recombinant human γ-interferon on the concentration of tryptophan in culture media. Cancer Res 1988; 48: 346–350
  • Carlin J M, Oxaki Y, Byrne G I, et al. Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effects. Experientia 1989; 45: 535–541
  • Yoshida R, Park S W, Yasui H, et al. Tryptophan degradation in transplanted tumor cells undergoing rejection. J Immunol 1988; 141: 2819–2823
  • Wooley P V, III, Dion R L, Bono V H, Jr. Effects of tryptophan deprivation on L1210 cells in culture. Cancer Res 1974; 34: 1010–1014
  • Roberts J, Schmid F A, Rosenfeld H J. Biologic and antineoplastic effects of enzyme-mediated in vivo depletion of L-glutamine, L-tryptophan, and L-histidine. Cancer Treat Rep 1979; 63: 1045–1054
  • Clemens J M, Tilleray V J, James R, et al. Relationship of cellular oncogene expression to inhibition of growth and induction of differentiation of Daudi cells by interferons or TPA. J Cell Biochem 1988; 38: 251–259
  • Jonak G J, Knight E, Jr. Selective reduction of c-myc RNA in Daudi cells by human beta interferon. Proc Natl Acad Sci USA 1984; 81: 1747–1750
  • Kimchi A. Autocrine interferon and the suppression of the c-myc oncogene. Interferon 1987; 8: 87–110
  • Resnitzky D, Yarden A, Zipori D, Kimchi A. Autocrine beta-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell 1993; 46: 31–40
  • Gonda T J, Metcalf D. Expression of myb, myc and fos protooncogenes during the differentiation of a murine myeloid leukaemia. Nature 1984; 310: 249–251
  • Einal M, Resnitzky D, Kimchi A. Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor. Proc Natl Acad Sci USA 1985; 82: 7608–7612
  • Marth C, Cronauer M V, Doppler W, Ofner D, Ullrich A, Daxenbichler G. Effects of interferons on the expression of the proto-oncogene her-2 in human ovarian carcinoma cells. Int J Cancer 1992; 50: 64–68
  • Souslau G, Bogucki A R, Gillespie D, Hubbell H R. Phosphoproteins altered by antiproliferative doses of human interferon-beta in a human bladder carcinoma cell line. Biochem Biophys Res Commun 1984; 119: 941–948
  • Samid D, Flessate D M, Greene J J, Chang E H, Friedman R M. Persisting revertants after interferon treatment of oncogene-transformed cells. The Biology of the Interferon System, W E Stewart, II, H Schellekens. Elsevier, Amsterdam 1984; 327–332
  • Lin S L, Barber E A, Wang E, Caliquiri L A, Schellekens H, Goldberg A R, Tamm I. Reduced synthesis of pp60src and expression of the transformation-related phenotype in interferon-treated Rous sarcoma virus-transformed rat cells. Mol Cell Biol 1983; 3: 1656–1664
  • Samid D, Chang F H, Friedman R M. Biochemical and biophysical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene. Biochem Biophys Res Commun 1984; 119: 21–28
  • Soslau G, Bogucki A R, Gillespie D, Hubbell H R. Phosphoproteins altered by antiproliferative doses of human interferon-beta in a human bladder carcinoma cell line. Biochem Biophys Res Commun 1984; 119: 941–948
  • Contente S, Kenyon K, Rimoldi D, Friedman R M. Expression of gene rrg is associated with reversion of NIH 3T3 transformed by LTR-c-H-rαs. Science 1990; 249: 796–798
  • Brouty Boye D, Gresser I. Reversibility of the transformed and neoplastic phenotype. I. Progressive reversion of the phenotype of X-ray transformed C3H/10T1/2 cells under prolonged treatment with interferon. Int JCancer 1981; 28: 165–173
  • Sergiescu D, Gerfaux J, Joret A M, Chany C. Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon. Proc Natl Acad Sci USA 1986; 83: 5764–5768
  • Levine A J. The tumor suppressor genes. Annu Rev Biochem 1993; 62: 623–651
  • Squire J, Meurs E F, Chong K L, et al. Localization of the human interferon-induced, ds-RNA activated p68 kinase gene (PKR) to chromosome 2p21-p22. Genomics 1993; 16: 768–770
  • Lengyel P L. Tumor-suppressor genes: News about the interferon connection. Proc Natl Acad Sci USA 1993; 90: 5893–5895
  • Kitajewski J, Schneider R, Safer B, et al. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2α kinase. Cell 1986; 45: 195–200
  • Galabru J, Katze M, Robert N, et al. The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur J Biochem 1989; 178: 581
  • Davies M V, Furtado M, Hershey J WB, et al. Complementation of adenovirus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor. Proc Natl Acad Sci USA 1989; 86: 9163–9167
  • Mathews M, Shenk T. Adenovirus virus-associated RNA and translation control. J Virol 1991; 65: 5657–5662
  • Ghadge G, Swaminathan S, Katze M, et al. Binding of the adeno-virus VAI RNA to the interferon-induced 68-kDa protein kinase correlates with function. Proc Natl Acad Sci USA 1991; 88: 7140–7144
  • Roy S, Katze M, Parkin N, et al. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 1990; 247: 1216–1219
  • Imani F, Jacobs B. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 α3 protein. Proc Natl Acad Sci USA 1988; 85: 7887–7891
  • Lee T, Tomita J, Hovanessian A, et al. Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc Natl Acad Sci USA 1990; 87: 6208–6212
  • Beattie E, Tartagglia J, Poaletti E. Vaccinia virus-encoded elF-2α homolog abrogates the antiviral effect of interferon. Virology 1991; 183: 419–422
  • Davies M V, Elroy-Stein O, Jagus R, et al. The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J Virol 1992; 1943–1950
  • Chang H-W, Watson J C, Jacobs B L. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci US A 1992; 89: 4825–4829
  • Akkaraju G, Whitaker-Dowling P, Youngner J, et al. Vaccinia specific kinase inhibitory factor prevents translational inhibition by double-stranded RNA in rabbit reticulocyte lysate. J Biol Chem 1989; 264: 10321–10325
  • Higashi Y, Sokawa Y. Microinjection of interferon and 2′-5′-oligoadenylate into mouse L cells and their effects on virus growth. J Biol Chem 1982; 91: 2021–2028
  • Zhou A, Hassel B A, Silverman R H. Expression cloning of 2–5A-dependent RNAase: A uniquely regulated mediator of interferon action. Cell 1993; 72: 753–765
  • Cayley P, Davies J, McCullagh K, et al. Activation of the ppp(A2′p)nA system in interferon-treated, herpes simplex virus-infected cells and evidence for novel inhibitors of the ppp(A2′p)nA-dependent RNase. Eur J Biochem 1984; 143: 165–174
  • Harada H, Kitagawa M, Tanaka N, et al. Antioncogenic and oncogenic potentials of interferon regulatory factors-1 and-2. Science 1993; 259: 971–974
  • Willman C L, Sever C E, Pallavicini M G, et al. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleu-kemic myelodysplasia. Science 1993; 259: 968–971
  • Anderson K P, Fennie E M. Adenovirus early region 1A modulation of interferon antiviral activity. J Virol 1987; 61: 787–795
  • Reich N, Pine R, Levy D, et al. Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products. J Virol 1988; 62: 114–119
  • Shenk T, Flint J. Transcriptional and transforming activities of the adenovirus E1A proteins. Adv Cancer Res 1991; 57: 47–85
  • Ackrill A M, Foster G R, Laxton C D, et al. Inhibition of the cellular response to interferons by products of the adenovirus type 5 ElA oncogene. Nucleic Acids Res 1991; 20: 1531–1538
  • Gutch M J. Reich N Repression C. of the interferon signal trans-duction pathway by the adenovirus El A oncogene. Proc Natl Acad Sci U SA 1991; 88: 7913–7917
  • Kalvakolanu D V, Bandyopadhyay S K, Harter M L, et al. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: Block in transcriptional complex formation. Proc Natl Acad Sci USA 1991; 88: 7459–7463
  • Imperiale M J, Kao H-T, Feldman L T, et al. Common control of the heat shock gene and early adenovirus genes: Evidence for a cellular El A-like activity. Mol Cell Biol 1984; 4: 867–874
  • Kalvakolanu D VR, Sen G C. Differentiation-dependent activation of interferon-stimulated gene factors and transcription factor NF-KB in mouse embryonal carcinoma cells. Proc Natl Acad Sci US A 1993; 90: 3167–3171
  • Suemori H, Hashimoto S, Nakatsuji N. Presence of the adenovirus ElA-like activity in preimplantation stage mouse embryos. Mol Cell Biol 1988; 8: 3553–3555
  • Jacyna M R, Thomas H C. Antiviral therapy: Hepatitis B. Br Med Bull 1990; 46: 368–382
  • Foster G, Ackrill A, Goldin R, et al. Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons α and γ and double-stranded RNA. Proc Natl Acad Sci US A 1991; 88: 2888–2892
  • Kerr I M, Stark G R. The antiviral effects of the interferons and their inhibition. J Interferon Res 1992; 12: 237–240
  • Whitten T M, Quets A T, Schloemer R H. Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J Virol 1991; 65: 4699–4704
  • Straus S E, Cohen J I, Tosato G, et al. Epstein-Barr virus infections: Biology, pathogenesis, and management. Ann Intern Med 1993; 118: 45–58
  • Kanda K, Decker T, Aman P, et al. The EBNA-2 related resistance towards alpha interferon (IFN-alpha) in Burkitt′s lymphoma cells effects induction of IFN-stimulated genes but not the activation of transcription factor ISGF-3. Mol Cell Biol 1992; 12: 4930–4936
  • Cohen J I, Picchio G R, Mosier D E. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro. J Virol 1992; 66: 7555–7559
  • Sinclair A J, Farrell P J. Epstein-Barr virus transcription factors. Cell Growth Diff 1992; 3: 557–563
  • Buller R M, Palumbo G J. Poxvirus pathogenesis. Microbiol Rev 1991; 55: 80–122
  • Kotwal G J, Moss B. Vaccinia virus encodes a secretory polypep-tide structurally related to complement control proteins. Nature 1988; 335: 176–178
  • Smith C A, Davis T, Anderson D, et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990; 248: 1019–1023
  • Smith C A, Davis T, Wignall J M, et al. T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun 1991; 176: 335–342
  • Upton C, Mossman K, McFadden G. Encoding of a homolog of the IFN-γ receptor by myxoma virus. Science 1992; 258: 1369–1372
  • Williams B RG. Review: Transcriptional regulation of interferon-stimulated genes. Eur J Biochem 1991; 200: 1–11
  • Foon K A. Biological response modifiers: The new immuno-therapy. Cancer Res 1989; 49: 1621–1639
  • Roller B H, Orr H T. Cloning and complete sequence of an HLA-A2 gene: Analysis of two HLA-A alleles at the nucleotide level. J Immunol 1985; 134: 2727–2733
  • Wu L-C, Merely B J, Campbell R D. Cell specific expression of the human complement protein factor B gene: Evidence for the role of two distinct 5′-flanking elements. Cell 1987; 48: 331–342
  • Luster A D, Ravetch J V. Genomic characterization of a gammainterferon-inducible gene (IP-10) and identification of an inter-feron-inducible hypersensitive site. Mol Cell Biol 1987; 7: 3723–3731
  • Chang K C, Hansen E, Foroni L, et al. Molecular and functional analysis of the virus and interferon-inducible human mx A promoter. Arch Virol 1991; 117: 1–15
  • Kimura A, Israel A, Le Bail O, et al. Detailed analysis of the mouse H-2Kb promoter: Enhancer-like sequences and their role in the regulation of class I gene expression. Cell 1986; 44: 261–272
  • Korber B, Mermod N, Hood L, et al. Regulation of gene expression by interferon: Control of H2-promoter responses. Science 1988; 239: 1302–1306
  • Samanta H, Engel D, Chao H, et al. Interferons as gene activators: Cloning of the 5′ terminus and the control segment of an interferon activated gene. J Biol Chem 1986; 261: 11849–11858
  • Strehlow I, Seegert D, Frick C, et al. The gene encoding IFP 53/tryptophanyl-tRNA synthetase is regulated by gamma-inter-feron activation factor. J Biol Chem 1993; 268: 16590–16595
  • Wright T M, Farber J M. 5′ regulatory region of a novel cytokine gene mediates selective activation by interferon gamma. J Exp Med 1991; 173: 417–422
  • Reith W, Barras E, Satola S, et al. Cloning of the major histocom-patibility complex class II promoter binding protein affected in a hereditary defect in class II gene regulation. Proc Natl Acad Sci USA 1989; 86: 4200–4204
  • Reith W, Herero-Sanchez C, Kobr M, et al. MHC class II regulatory factor RFX has novel DNA-binding domain and a functionally independent dimerization domain. Genes Dev 1990; 4: 1528–1540
  • Liou H-C, Boothby M R, Finn P W, et al. A new member of the leucine zipper class of proteins that binds to the HLA DR-alpha promoter. Science 1990; 247: 1581–1584
  • Ono S J, Liou H C, Davidon R, et al. Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. Proc Natl Acad Sci USA 1991; 88: 4309–4312
  • Ono S, Bazil V, Levi B-Z, et al. Transcription of a subset of human class II major histocompatibility complex genes is regulated by a nucleoprotein complex that contains c-fos or an antigenically related protein. Proc Natl Acad Sci USA 1991; 88: 4304–4308
  • Kieran M, Blank V, Logeat F, et al. The DNA binding subunit of NF-KB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 1990; 62: 1007–1018
  • Wallach D, Fellous M, Revel M. Preferential effect of γ-interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature 1982; 299: 834–836
  • Chebath J, Merlin G, Metz R, et al. Interferon-induced 56,000 Mr protein and its mRNA in human cells: Molecular cloning and partial sequences of the cDNA. Nucleic Acids Res 1983; 11: 1213–1226
  • Vanguri P, Farber J M. Identification of CRG-2: An interferon-inducible mRNA predicted to encode a murine monokine. J Biol Chem 1990; 265: 15049–15057
  • Shan B, Vazquez E, Lewis J A. Interferon selectively inhibits the expression of mitochondrial genes: A novel pathway for inter-feron-mediated responses. EMBO J 1990; 9: 4307–4314
  • Stuehr D, Marietta M. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ. J Immunol 1987; 139: 518–525
  • Stuehr D, Cho H, Kwon N, et al. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD-and FMN-containing flavoprotein. Proc Natl Acad Sci USA 1991; 88: 7773–7777
  • Levy D E, Larner A C, Chaudhuri A, et al. Interferon-stimulated transcription: Isolation of an inducible gene and identification of its regulatory region. Proc Natl Acad Sci USA 1986; 83: 8929–8933
  • Cassatella M, Bazzoni F, Calzetti F, et al. Interferon-γ transcriptionally modulates the expression of the genes for the high affinity IgG-Fc receptor and the 47-kDa cytosolic component of NADPH oxidase in human plymorphonuclear leukocytes. J Biol Chem 1991; 266: 22079–22082
  • Staeheli P, Prochazka M, Steigmeier P, Haller O. Genetic control of interferon action: Mouse strain distribution an inheritance of an induced protein with guanylate-binding property. Virology 1984; 137: 135–142
  • Cheng Y, Becker-Manley M, Chow T, et al. Affinity purification of an interferon-induced human guanylate-binding protein and its characterization. J Biol Chem 1985; 260: 15834–15839
  • Margolis-Nunno H, Rubin B, Anderson S, et al. Isolation of cDNA clones for the interferon-induced 67,000 dalton protein: Direct induction of a family of mRNAs by interferon-α and by interferonγ. J Interferon Res 1990; 10: 309–319
  • Rubin B Y, Anderson S L, Hellerman G R, et al. The development of antibody to the interferon-induced indoleamine 2,3-dioxygenase and the study of the regulation of its synthesis. J Interferon Res 1988; 8: 691–702
  • Haas A, Ahrens P, Bright P, et al. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 1987; 262: 11315–11323
  • Bange C-F, Vogel U, Flohr T, et al. IFP 35 is an interferon-α induced leucine zipper protein that undergoes interferon-regulated cellular redistribution. J Biol Chem 1994; 269: 1091–1098
  • Barr C L, Saunders G F. Interferon-γ-inducible regulation of the human invariant chain gene. J Biol Chem 1991; 266: 3475–3481
  • Luster A, Unkeless J, Ravetch J. γ-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985; 315: 672–676
  • Luster A, Weinshank R, Feinman R, et al. Molecular and biochemical characterization of a novel y-interferon-inducible protein. J Biol Chem 1988; 263: 12036–12043
  • Miyamoto M, Fijita T, Kimura Y, et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-gene regulatory elements. Cell 1988; 54: 903–913
  • Harris C A, Hunte B, Krauss M R, et al. Induction of leucine aminopeptidase by interferon-gamma: Identification byprotein microsequencing after purification by preparative two-dimensional gel electrophoresis. J Biol Chem 1992; 267: 6865–6869
  • Harris C A, Derbin K S, Hunte-McDonough B, et al. Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types: Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1. J Immunol 1991; 147: 149–154
  • Rubin B, Anderson S, Xing L, et al. Interferon induces typtophanyl tRNA synthetase expression in human fibroblasts. J Biol Chem 1991; 266: 24245–24248
  • Rosa F M, Fellous M. Regulation of HLA-DR gene by IFN-gamma: Transcriptional and post-transcriptional control. J Immunol 1988; 140: 1660–1664
  • Newburger P, Ezekkowitz R, Whitney C, et al. Induction of phagocyte cytochrome b heavy chain gene expression by interferon y. Proc Natl Acad Sci USA 1988; 85: 5215–5219
  • Robertson M. Antigen processing: Proteasomes in the pathway. Nature 1991; 353: 300–301
  • Parham P. Antigen processing: Transporters of delight. Nature 1990; 348: 674–675
  • Fan X, Stark G, Bloom B. Molecular cloning of a gene selectively induced by gamma interferon from human macrophage line U937. Mol Cell Biol 1989; 9: 1922–1928
  • Choubey D, Snoddy J, Chaturvedi V, et al. Interferons as gene activators: Indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome. J Biol Chem 1989; 264: 17182–17189
  • Katze M, De Corato D, Safer B, et al. Adenovirus VA1 RNA complexes with the 68000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J 1988; 6: 689–687
  • Clarke P, Schwemmle M, Schickinger J, et al. Binding of EpsteinBarr virus small RNA EBER-1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res 1991; 19: 243–248
  • Judware R, Li J, Petryshyn R. Inhibition of the dsRNA-dependent protein kinase by a peptide derived from the human immunodeficiency virus type 1 Tat protein!. Interferon Res 1993; 13: 153–160
  • Katze M, Tomita J, Black T, et al. Influenza virus regulates protein synthesis during infection by repressing autophosphorylation and activity of the cellular 68,000-Mr protein kinase. J Virol 1988; 62: 3710–3717
  • Darnell J E, Jr, Kerr I M, Stark G R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415–1421
  • Schindler C, Darnell J E, Jr. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway. Ann Rev Biochem 1995; 64: 621–651
  • Mignoe T-S, Lin J-X, Cereseto A, et al. Constitutively activated Jak-STAT pathway in T-cells transformed with HTLV-I. Science 1995; 269: 79–81
  • Yu C-L, Meyer D J, Campbell G S, et al. Enhanced DNA-binding of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995; 269: 81–83

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.